Presentation is loading. Please wait.

Presentation is loading. Please wait.

The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,

Published byHarold Bradley Modified over 5 years ago

Similar presentations

Presentation on theme: "The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,"— Presentation transcript:

1 The fate of small-size pericardial heart valve prostheses in an older patient population 
Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario, MD, Andrea Salica, MD, Luca P. Weltert, MD, Raffaele Scaffa, MD, Lorenzo Guerrieri Wolf, MD, Daniele Maselli, MD, Michele Di Mauro, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 153, Issue 1, Pages e2 (January 2017) DOI: /j.jtcvs Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Mean transprosthetic gradient average values and outliers in longitudinal echocardiography surveillance. *P < .05 versus discharge. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Overall survival and patients at risk in the whole patient population divided by size 19- or 21-mm Mitroflow valve prostheses (LivaNova, London, United Kingdom). The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Cardiac- and valve-related mortality and patients at risk, for the operative survivors. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

5 Figure 4 Freedom from reoperation because of structural valve deterioration (SVD) and patients at risk, for the operative survivors. AVR, Aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

6 Figure 5 Freedom from structural valve deterioration (SVD) (as defined by a mean gradient > 35 mm Hg) and patients at risk, for the operative survivors. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

7 Figure 6 Freedom from structural valve deterioration (SVD) (as defined by a mean gradient >35 mm Hg) and patients at risk, for the operative survivors, divided by the 2 sizes of implanted Mitroflow valve prostheses (LivaNova, London, United Kingdom). The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

8 Figure E1 Nomogram of time from implant expected freedom from structural valve deterioration (SVD) stratified by age-class. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

9 Freedom from structural valve deterioration in 19- and 21-mm Mitroflow valve prostheses (LivaNova, London, United Kingdom). The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,"

Similar presentations

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P
Operative outcomes in mitral valve surgery: Combined effect of surgeon and hospital volume in a population-based analysis  Arman Kilic, MD, Ashish S.

Operative outcomes in mitral valve surgery: Combined effect of surgeon and hospital volume in a population-based analysis  Arman Kilic, MD, Ashish S.
Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion

Of mice and men and surgical transcatheter aortic valve insertion
The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,

The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,
Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study  Vincent Chan,

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study  Vincent Chan,
A wolf in sheep's clothing

A wolf in sheep's clothing
Scott Goldman, MD, Anson Cheung, MD, Joseph E. Bavaria, MD, Michael R

Scott Goldman, MD, Anson Cheung, MD, Joseph E. Bavaria, MD, Michael R
Reoperative aortic valve replacement in the octogenarians—minimally invasive technique in the era of transcatheter valve replacement  Tsuyoshi Kaneko,

Reoperative aortic valve replacement in the octogenarians—minimally invasive technique in the era of transcatheter valve replacement  Tsuyoshi Kaneko,
In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results.

In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results.
Fate of aortic bioprostheses: An 18-year experience

Fate of aortic bioprostheses: An 18-year experience
Harald C. Eichstaedt, MD, Jerry Easo, MD, Tobias Härle, MD, Otto E

Harald C. Eichstaedt, MD, Jerry Easo, MD, Tobias Härle, MD, Otto E
Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier–Edwards.

Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier–Edwards.
Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis  Evaldas Girdauskas,

Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis  Evaldas Girdauskas,
When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 

When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 
Aortic valve replacement: Results and predictors of mortality from a contemporary series of 2256 patients  Marco Di Eusanio, MD, PhD, Daniela Fortuna,

Aortic valve replacement: Results and predictors of mortality from a contemporary series of 2256 patients  Marco Di Eusanio, MD, PhD, Daniela Fortuna,
Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society.

Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society.
Mitral mechanical replacement in young rheumatic women: Analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year.

Mitral mechanical replacement in young rheumatic women: Analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year.
Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age  Torsten Christ,

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age  Torsten Christ,

Similar presentations

Ads by Google